BCM
BSX icon

BlueCrest Capital Management’s Boston Scientific BSX Stock Holding History

BlueCrest Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,600
Closed -$230K – 213
2023
Q1 		$230K Buy
+4,600
New +$217K 0.01% 240
2022
Q3 		– Sell
-67,975
Closed -$2.53M – 194
2022
Q2 		$2.53M Buy
+67,975
New +$2.77M 0.1% 101
2021
Q3 		– Sell
-71,254
Closed -$3.05M – 382
2021
Q2 		$3.05M Buy
+71,254
New +$3M 0.06% 276
2021
Q1 		– Sell
-183,363
Closed -$6.59M – 638
2020
Q4 		$6.59M Buy
183,363
+75,614
+70% +$2.73M 0.15% 157
2020
Q3 		$4.12M Buy
+107,749
New +$4.15M 0.15% 133
2019
Q4 		– Sell
-6,426
Closed -$261K – 412
2019
Q3 		$261K Buy
+6,426
New +$272K 0.02% 410
2019
Q2 		– Sell
-31,762
Closed -$1.22M – 488
2019
Q1 		$1.22M Buy
31,762
+16,092
+103% +$615K 0.05% 265
2018
Q4 		$554K Buy
15,670
+1,317
+9% +$47.8K 0.03% 327
2018
Q3 		$553K Buy
+14,353
New +$501K 0.01% 697
2018
Q1 		– Sell
-21,259
Closed -$527K – 1487
2017
Q4 		$527K Buy
+21,259
New +$586K 0.01% 525
2017
Q2 		– Sell
-32,458
Closed -$807K – 922
2017
Q1 		$807K Buy
32,458
+9,458
+41% +$230K 0.04% 353
2016
Q4 		$497K Buy
23,000
+1,248
+6% +$27.2K 0.03% 469
2016
Q3 		$518K Sell
21,752
-194,345
-90% -$4.64M 0.02% 510
2016
Q2 		$5.05M Buy
+216,097
New +$4.67M 0.21% 113
2015
Q2 		– Sell
-159,585
Closed -$2.83M – 795
2015
Q1 		$2.83M Buy
+159,585
New +$2.52M 0.15% 193

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

BlueCrest Capital Management's BSX Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 4,600 shares — an estimated $230K sold.

BlueCrest Capital Management first reported a position in BSX in Q1 2015 and held it in 15 quarters. The position peaked at $6.59M in Q4 2020. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,600 Boston Scientific shares in Q2 2023, an estimated $230K.
  • BlueCrest Capital Management first reported a position in Boston Scientific in Q1 2015 and held it in 15 quarters.
  • BlueCrest Capital Management's Boston Scientific position peaked at $6.59M in Q4 2020.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.